NM_024649.5:c.1169T>G

Variant summary

Our verdict is Likely pathogenic.
+9 Likely Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 9 classification points (ACMG Germline Pathogenicity v2019). PS3PP3PP5_Strong

The NM_024649.5(BBS1):c.1169T>G (p.Met390Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00268 (AC=4,322) in the gnomAD database across 1,614,180 control chromosomes, including 2 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.00329. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000373275: A homozygous knock-in mouse line carrying the Met390Arg variant showed a phenotype that included retinal degeneration, male infertility, and obesity (PMID:18032602)." and additional evidence is available in ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.M390V: Uncertain_significance (ClinVar VariationId 1979201, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.0020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 2 hom. )

Consequence

BBS1
NM_024649.5 missense

Scores

5
13
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:63O:2

Conservation

PhyloP100: 4.70

Publications

1 publications found
Variant links:
Genes affected
BBS1 (HGNC:966): (Bardet-Biedl syndrome 1) Mutations in this gene have been observed in patients with the major form (type 1) of Bardet-Biedl syndrome. The encoded protein may play a role in eye, limb, cardiac and reproductive system development. [provided by RefSeq, Jul 2008]
BBS1 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women's Health, PanelApp Australia, Natera, Ambry Genetics, Genomics England PanelApp, G2P
  • BBS1-related ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
ZDHHC24 (HGNC:27387): (zDHHC palmitoyltransferase 24) Predicted to enable protein-cysteine S-palmitoyltransferase activity. Predicted to be involved in protein targeting to membrane. Predicted to be located in membrane. Predicted to be active in Golgi apparatus and endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_024649.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Likely_pathogenic. The variant received 9 points.

PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV000373275: A homozygous knock-in mouse line carrying the Met390Arg variant showed a phenotype that included retinal degeneration, male infertility, and obesity (PMID: 18032602).; SCV001573536: Well-established functional studies show a deleterious effect (PS3).; SCV002058656: Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 12118255, 12677556, 22940089, 23143442).; SCV002503686: A knock-in mouse model homozygous for p.Met390Arg has cilia defects, and recapitulates aspects of the human BBS phenotype, including retinal degeneration, male infertility, and obesity (PMID: 18032602), and partial rescue (hypomorph) was demonstrated in a zebrafish assay (PMID: 20498079).; SCV000329106: Published functional studies demonstrate a damaging effect as mice homozygous for the M390R variant develop cilia defects, ventriculomegaly, retinopathy, and obesity (Davis et al., 2007);; SCV000253934: Experimental studies have shown that this missense change affects BBS1 function (PMID: 15314642, 18032602, 20498079).; SCV000699512: An in vivo BBS mouse model shows that mice homozygous for the M390R mutation recapitulate aspects of the human phenotype, including retinal degeneration, male infertility, and obesity (Davis_PNAS_2007).; SCV000712198: Animal models in mice have shown that this variant causes Bardet-Biedl syndrome (Davis 2007).; SCV003539679: Functional studies in zebrafish lacking BBS1 and co-injected with wildtype mRNA and this mutation demonstrated only a partial rescue, consistent with a possible hypomorphic effect of this variant (Zaghloul, 2010).; SCV004120938: "In vivo and in vitro studies suggest that this variant impacts protein function (Davis et al. 2007. PubMed ID: 18032602; Zaghloul et al. 2010. PubMed ID: 20498079)."
PP3Computational evidence supports damaging effect
Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — supporting evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Supporting).
PP5Reputable source reports pathogenic
ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (63/63 total P/LP).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_024649.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

BBS1 NM_024649.5
MANE Select
HGVSc / HGVSpc.1169T>Gp.Met390Arg
Exon rankExon 12 of 17
missense
Prot: NP_078925.3
ZDHHC24 NM_001348571.2
HGVSc / HGVSpc.*21+755A>C
Exon rankIntron 4 of 4
intron
Prot: NP_001335500.1UniProt: E9PLR9

Ensembl Transcripts

BBS1 ENST00000318312.12
TSL:1MANE Select
HGVSc / HGVSpc.1169T>Gp.Met390Arg
Exon rankExon 12 of 17
missense
Prot: ENSP00000317469.7UniProt: Q8NFJ9-1
ENSG00000256349 ENST00000419755.3
TSL:2
HGVSc / HGVSpc.1280T>Gp.Met427Arg
Exon rankExon 12 of 17
missense
Prot: ENSP00000398526.3UniProt: Q8NFJ9-2
BBS1 ENST00000393994.4
TSL:1
HGVSc / HGVSpc.782T>Gp.Met261Arg
Exon rankExon 9 of 13
missense
Prot: ENSP00000377563.2UniProt: Q8NFJ9-3

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.00205
AC:312
Hom:0
AN:152210
Cov:32
GnomAD2 exomes
AF: 0.00151
AC:380
AN:251388
GnomAD4 exome
AF: 0.00274
AC:4010
Hom:2
AN:1461852
Cov:31
GnomAD4 genome
AF: 0.00205
AC:312
Hom:0
AN:152328
Cov:32
TOPMed (Bravo)
AF: 0.00210
AC:556
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00223
AC:1167
Hom:1
AN:522958
Local & regional cohorts 5 sources
ABraOM SABE-WGS-1171
AF: 0.00256
AC:6
Hom:0
AN:2342
Denmark Genome
AF: 0.00333
AC:1
AN:300
ESP6500 (Exome Variant Server)
AF: 0.00200
AC:26
AN:12990
GenomeAsia100K
AF: 0.000289
AC:1
AN:3478
UK10K
AF: 0.00357
AC:27
AN:7562
Showing 11 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.00207 *2311112 0.00199 *3517618
BipEx
(Bipolar disorder (including schizoaffective))
0.00260 7428420 0.00239 6928844
Epi25
(Epilepsy)
0.00186 7841956 0.00232 15566882
SCHEMA
(Schizophrenia)
0.00169 206121772 0.00248 474190810
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
27
-
-
Bardet-Biedl syndrome 1 (28)
13
-
-
not provided (13)
10
-
-
Bardet-Biedl syndrome (11)
4
-
-
Retinal dystrophy (4)
3
-
-
Retinitis pigmentosa (3)
1
-
-
BBS1-related disorder (1)
1
-
-
Inborn genetic diseases (1)
1
-
-
Retinal disorder (1)
1
-
-
See cases (1)
1
-
-
Severe early-childhood-onset retinal dystrophy (1)
1
-
-
Usher syndrome (1)

Computational Scores

AlphaGenome AVI
Pathogenic26
AlphaMissense
Pathogenic0.85
BayesDel_addAF
Uncertain0.084D
BayesDel_noAF
Pathogenic0.35
CADD
Uncertain25
DANN
Uncertain0.98
DEOGEN2
Uncertain0.75D
Eigen
Uncertain0.49
Eigen_PC
Uncertain0.49
FATHMM_MKL
Pathogenic0.99D
GPN-Star LLR
N/A-7.8
GPN-Star score
N/A7.8
LIST_S2
Uncertain0.92D
M_CAP
Uncertain0.12D
MetaRNN
Benign0.081T
MetaSVM
Uncertain0.73D
Mutation Taster
N/A14/86disease causing (ClinVar)
MutationAssessor
Uncertain2.2M
PhyloP100
Uncertain4.7
popEVE
Benign-4.1
PrimateAI
Uncertain0.71T
PROVEAN
Uncertain-4.0D
REVEL
Pathogenic0.66
Sift
Uncertain0.012D
Sift4G
Uncertain0.0080D
Varity_R
N/A0.90
VESM-3B
Benign-15
Showing 27 of 27 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.010
Details are displayed if max score is > 0.2
Splicevardb
N/A2.0
Showing 3 of 3 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs113624356;
hg19: chr11-66293652;
COSMIC: COSV99041500;
COSMIC: COSV99041500;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.